B. Strober, “Measuring GPPGA, Pain, Symptom, and Quality of Life Index Scores in Untreated Generalized Pustular Psoriasis: Results from the Placebo Group of the Effisayil-2 Trial”, J of Skin, vol. 8, no. 2, p. s361, Mar. 2024.